Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Toward finding the difference between untreated celiac disease and COVID-19 infected patients in terms of CD4, CD25 (IL-2 Rα), FOXP3 and IL-6 expressions as genes affecting immune homeostasis

Fig. 2

Analysis of relative expression levels in CD and COVID-19 patients compared to normal controls using real-time PCR assay. All expression levels are normalized to that of GAPDH. The analysed genes were as follows: A CD4; *p = 0.02, ****p < 0.0001, B CD25; *p = 0.01 (between COVID-19 patients and controls) and p = 0.03 (between CD patients and controls), ****p < 0.0001; C FOXP3; **p = 0.007, ****p < 0.0001; D IL-6; ****p < 0.0001. Data are presented as mean ± S.D. CD celiac disease, COVID-19 coronavirus disease 2019, GAPDH glyceraldehyde 3-phosphate dehydrogenase, FOXP3 forkhead box P3

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us